News

Media

Conferences

Publications

Clinical

Events

Resources

Osteoporosis Drug Approval Highlights AJPB Week in Review

May 25, 2018

Article

Top news of the week from The American Journal of Pharmacy Benefits.

5. FDA Grants Breakthrough Therapy, Fast Track Designations to Narcolepsy Treatment

The FDA has granted Harmony Biosciences a Breakthrough Therapy designation for pitolisant, an investigational therapy for the treatment of cataplexy in patients with narcolepsy.

Recent Videos

Image Credit: © Pixel-Shot - stock.adobe.com.

Non Small Cell Lung Cancer (NSCLC) in the lung tissue – closeup view 3d illustration

Covid-19 Vaccine New Variant 2024-2025 | Image Credit: New Africa - stock.adobe.com

patients, btk, therapy, important, inhibitor, agents, mutation, bcl, targeted therapy, factor, toxicity, cll, influence, treatment, response, mutational, gave, chronic lymphocytic leukemia, targeted, ngs

lymphoma, mrd, assays, trials, tests, tumor, subtypes, guide, tracking, treatment, therapy, reporters, identify, circulating, sequencing, patients, results, mantle cell lymphoma, tumor dna, seq

Pharmacy students, university, assignment, tiktok | Image Credit: .shock - stock.adobe.com

toxicities, therapies, lymphoma, t cell, target, antigen, drug, response, predictive, t cell lymphoma, shown, agents, higher response rate, pathway, patients, prognostic, ccr, immune cells, aggressive, antibody

Exploring T-Cell–Directed Therapies for Indolent B-cell Lymphoma

Pharmacy Students in Lab, TikTok | Image Credit: D Lahoud/peopleimages.com - adobe.stock.com

Trisha Winroth, PharmD, and Ashly McPhilips, PharmD

Consent Preferences

Clinical Forums

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.